Pavlo Gonchar | LightRocket | Getty Images
Johnson & Johnson on Tuesday sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.
The lawsuit filed in federal district court in New Jersey argues the Medicare negotiations violate the First and Fifth Amendments of the U.S. Constitution.
Earlier suits brought separately by drugmakers Merck and Bristol Myers Squibb, as well as by the U.S. Chamber of Commerce and PhRMA, the pharmaceutical industry’s largest lobbying group, made similar arguments.
J&J’s complaint asks a judge to block the U.S. Health and Human Services Department from compelling the drugmaker to participate in the program.
The company said its suit aims to stop the “johnson-johnson-files-lawsuit-against-biden-administration-regarding-medicare-drug-negotiations.html” title=”Johnson & Johnson files lawsuit against Biden administration regarding Medicare drug negotiations”>innovation-damaging congressional overreach that threatens the United States’ primacy in developing transformative therapies and in patients’ access to those…
2023-07-18 13:37:07
Source from www.cnbc.com